These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 1281076

  • 1. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
    Frampton J, Buckley MM, Fitton A.
    Drugs; 1992 Oct; 44(4):625-55. PubMed ID: 1281076
    [Abstract] [Full Text] [Related]

  • 2. Pharmacology and therapeutic effects of nicorandil.
    Kinoshita M, Sakai K.
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1075-88. PubMed ID: 2150592
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Safety profile of an anti-anginal agent with potassium channel opening activity: an overview.
    Roland E.
    Eur Heart J; 1993 Jul; 14 Suppl B():48-52. PubMed ID: 8370373
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of nicorandil on rest and effort angina unresponsive to combination therapy with a calcium antagonist and oral nitrate.
    Araki H, Hayata N, Matsuguchi T, Nakamura M.
    Clin Ther; 1987 Jul; 9(2):174-82. PubMed ID: 2952276
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
    Ulvenstam G, Diderholm E, Frithz G, Gudbrandsson T, Hedbäck B, Höglund C, Moelstad P, Perk J, Sverrisson JT.
    J Cardiovasc Pharmacol; 1992 Jul; 20 Suppl 3():S67-73. PubMed ID: 1282179
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris.
    Guermonprez JL, Blin P, Peterlongo F.
    Eur Heart J; 1993 Jul; 14 Suppl B():30-4. PubMed ID: 8370370
    [Abstract] [Full Text] [Related]

  • 14. Nicorandil for angina.
    Drug Ther Bull; 1995 Dec; 33(12):89-92. PubMed ID: 8777891
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A potassium channel opener as monotherapy in chronic stable angina pectoris: comparison with placebo.
    Why HJ, Richardson PJ.
    Eur Heart J; 1993 Jul; 14 Suppl B():25-9. PubMed ID: 8370369
    [Abstract] [Full Text] [Related]

  • 17. Nicorandil: animal pharmacology.
    Sakai K.
    Am J Cardiol; 1989 Jun 20; 63(21):2J-10J. PubMed ID: 2525321
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Potassium channel openers: clinical applications in ischemic heart disease--overview of clinical efficacy of nicorandil.
    Knight C, Purcell H, Fox K.
    Cardiovasc Drugs Ther; 1995 Mar 20; 9 Suppl 2():229-36. PubMed ID: 7647027
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.